Posted in | News | Gold

New Gold Targets Identified at AMI's Anuoro License in Ghana

AMI Resources Inc. (TSX-V Symbol AMU) has received from Newmont Ghana Gold Limited, a subsidiary of Newmont Mining Corporation (NYSE:NEM) an update on exploration activities with respect to Newmont's option to earn into AMI's Anuoro license in Ghana, West Africa.

A total of 715 soil samples were collected in the month of September to conclude the initial phase of soil sampling. A new parallel soil anomaly with maximum Au in soil value of 410 ppb and measuring, at least 1.6 km long by 0.3 km wide has been identified on the license. Infill soil lines are planned. A number of blocks of ground IP/Resistivity surveys will be conducted over both the old and new soil anomalies. This should contribute in mapping out potential mineralized structures and also better define drill targets.

Newmont has also completed 25 Reverse Circulation drill holes totaling 2,300m over untested soil anomalies which lie outside of the NI43-101 compliant 100,000 ounce Mineral Resource identified by AMI on the Anuoro North Prospect.

The results from this initial drill program look promising. Gold mineralization appears to be associated with pinkish feldspar and sericite alteration plus disseminated pyrites within granodioritic rocks as well as quartz veining in the Tarkwaian/Birimian sediment contact.

The Anuoro License covers 126 sq km on the Ashanti Shear and is approximately 25 km to the northwest Newmont's Akyem gold deposit (7.7 million ounces in reserves as of the end of 2009). Newmont has the option to earn up to a 75% interest in the Anuoro license by spending US$4 million in exploration expenditures and property payments.

Simon Meadows-Smith, SEMS Exploration Services Ltd. a consulting geologist to AMI is a qualified person within the meaning of NI43-101 and has reviewed the scientific and technical information contained in this news item.

Source:

AMI RESOURCES INC.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.